| Indicators | Browse All

Q/C Technologies, Inc. (QCLS)

Technology | Computer Hardware | New York, United States | NasdaqCM
0.56 USD +0.02 (3.317%) ⇧ (Oct. 15, 2026, 4 p.m. EDT)

Short-term:★☆☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 9:22 a.m. EDT

The immediate outlook is severely clouded by a relentless multi-year price collapse. The stock has endured four consecutive years of negative annual returns, culminating in a staggering 97.58% drop last year and a total loss of nearly 100% over the nine-year observation window. This structural deterioration suggests the market has permanently reassessed the business quality downward, rendering any recent price fluctuations or speculative headlines about 'optical AI' or endorsements from figures like Martin Shkreli as noise against a backdrop of fundamental implosion. The company is burning cash aggressively, with operating and free cash flows deeply negative, while returning negative returns on both assets and equity. With no dividend history to speak of and a balance sheet showing significant debt relative to equity alongside massive losses, there is no safety net for investors. The statistical models correctly flag the short-term path as uncertain and likely negative, reflecting the gravity of the situation rather than a trading opportunity. This is a classic value trap where the low price reflects a broken business model, not a bargain.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.458679
AutoETS0.461384
MSTL0.464672
AutoARIMA0.469248

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 16%
H-stat 45.54
Ljung-Box p 0.000
Jarque-Bera p 0.000
Excess Kurtosis 2.25
Attribute Value
Sector Technology
Debt to Equity Ratio 1.946
Market Cap 4,565,834
Trailing P/E 0.21
Beta 2.33
Previous Name MyMD Pharmaceuticals, Inc.
Website https://www.qctechnologies.com

Info Dump

Attribute Value
52 Week Change -0.8728929
Address1 1,185 Avenue of the Americas
Address2 Suite 249
All Time High 6,566,400.0
All Time Low 0.42
Ask 1.46
Ask Size 1
Average Daily Volume10 Day 246,170
Average Daily Volume3 Month 4,974,745
Average Volume 4,974,745
Average Volume10Days 246,170
Beta 2.33
Bid 0.5809
Bid Size 1
Book Value 1.947
City New York
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 0.5575
Current Ratio 3.293
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 0.5899
Day Low 0.5347
Debt To Equity 1.946
Display Name Q/C
Dividend Yield 0.0
Ebitda Margins 0.0
Enterprise Value -2,922,485
Eps Trailing Twelve Months 2.62
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 1.60196
Fifty Day Average Change -1.0444599
Fifty Day Average Change Percent -0.6519888
Fifty Two Week Change Percent -87.28929
Fifty Two Week High 8.17
Fifty Two Week High Change -7.6125
Fifty Two Week High Change Percent -0.9317626
Fifty Two Week Low 0.42
Fifty Two Week Low Change 0.13750002
Fifty Two Week Low Change Percent 0.327381
Fifty Two Week Range 0.42 - 8.17
Financial Currency USD
First Trade Date Milliseconds 1,390,487,400,000
Float Shares 7,902,457
Free Cashflow -5,953,920
Full Exchange Name NasdaqCM
Full Time Employees 3
Fullday Change -0.0019999743
Fullday Change Percent -0.35745743
Fullday Price 0.5575
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Held Percent Insiders 0.07531
Held Percent Institutions 0.09020001
Implied Shares Outstanding 8,189,838
Industry Computer Hardware
Industry Disp Computer Hardware
Industry Key computer-hardware
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,756,771,200
Last Split Factor 1:100
Long Business Summary Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog derivative of cannabidiol (CBD) to treat various conditions, including epilepsy, pain and anxiety/depression. In addition, it is involved in the development and eventual application of quantum computing technology, both for cryptocurrency applications;. The company was formerly known as TNF Pharmaceuticals, Inc. and changed its name to Q/C Technologies, Inc. in September 2025. The company was founded in 2014 and is headquartered in New York, New York.
Long Name Q/C Technologies, Inc.
Market us_market
Market Cap 4,565,834
Market State PRE
Max Age 86,400
Message Board Id finmb_694917951
Most Recent Quarter 1,782,777,600
Name Change Date 2,026-10-16
Net Income To Common -18,341,612
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 7,166,108
Open 0.5347
Operating Cashflow -9,465,108
Operating Margins 0.0
Payout Ratio 0.0
Phone 856 848 8698
Pre Market Change -0.0019999743
Pre Market Change Percent -0.35745743
Pre Market Price 0.5575
Pre Market Time 1,792,147,510
Prev Name MyMD Pharmaceuticals, Inc.
Previous Close 0.5396
Price Hint 4
Price To Book 0.28633794
Profit Margins 0.0
Quick Ratio 3.086
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.01789999
Regular Market Change Percent 3.31727
Regular Market Day High 0.5899
Regular Market Day Low 0.5347
Regular Market Day Range 0.5347 - 0.5899
Regular Market Open 0.5347
Regular Market Previous Close 0.5396
Regular Market Price 0.5575
Regular Market Time 1,792,094,400
Regular Market Volume 131,645
Return On Assets -0.33443
Return On Equity -1.08004
Sand P52 Week Change 0.16207206
Sector Technology
Sector Disp Technology
Sector Key technology
Shares Outstanding 8,189,838
Shares Percent Shares Out 0.1157
Shares Short 947,657
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 1,418,598
Short Name Q/C Technologies, Inc.
Short Percent Of Float 0.52919996
Short Ratio 0.07
Source Interval 15
State NY
Symbol QCLS
Total Cash 10,987,394
Total Cash Per Share 1.342
Total Debt 371,171
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps 2.62
Trailing P E 0.21278627
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 3.292215
Two Hundred Day Average Change -2.734715
Two Hundred Day Average Change Percent -0.83066106
Type Disp Equity
Volume 131,645
Website https://www.qctechnologies.com
Zip 10,036